Net value change of +$9.17B, 1,298 buyers vs 1,035 sellers, and 240 new positions against 145 exits. Insider data is absent, but institutional flows alone provide a clear accumulation signal.

Confirmation

Sustained net buying in the next 13F filing would confirm the upward institutional trend.

Invalidation Risk

A flip to net institutional selling or an adverse corporate event would break the bullish thesis.

The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice and should not be used as the basis for any buy or sell decision.

Insider Trading (Form 4)

12-Month Buy/Sell Activity

Feb 25

Aug 25

BuySell

操作	內部人	職稱	交易日	金額
賣出	Elkins David V	EVP, Chief Financial Officer	2025-09-02	$2.65M
賣出	Short Bartie Wendy	EVP, Corporate Affairs	2025-08-02	$17K
賣出	Hickey Benjamin	President, RayzeBio Org.	2025-05-09	$4K
買入	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	2025-04-25	$202K
買入	BOERNER CHRISTOPHER S.	Chief Executive Officer	2025-02-20	$110K
買入	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	2025-02-14	$100K

View all insider trades →

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding BRISTOL-MYERS SQUIBB CO (BMY)?

Major stakeholders currently include Douglas Lane & Associates, LLC ($89.7M), Handelsbanken Fonder AB ($52.4M), Aegon Asset Management UK PLC ($36.6M). Based on the latest 13F filings, there are a total of 223 tracked investment funds and institutions maintaining positions in BMY.

What is the overall institutional sentiment toward BMY recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $99.4B, driven by 102 managers accumulating shares while 96 reduced their exposure.

Which institutions have been selling or reducing their BMY positions?

In the latest period, 81 funds trimmed their holdings, and 15 managers completely exited their positions. The aggregate reported sell value was $334.0M.

Are there any notable investors adding BMY to their portfolios?

Yes, buying activity remains notable. 6 institutions opened new positions in {ticker}, and 96 existing holders added to their shares. The total reported buy value for the quarter amounted to $337.4M.